174 related articles for article (PubMed ID: 8789376)
21. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
Michaud N; Couture R
Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
[TBL] [Abstract][Full Text] [Related]
22. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
Picard P; Chrétien L; Couture R
Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
[TBL] [Abstract][Full Text] [Related]
23. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular responses induced by intrathecal substance P in the conscious freely moving rat.
Hasséssian H; Couture R
J Cardiovasc Pharmacol; 1989 Apr; 13(4):594-602. PubMed ID: 2470997
[TBL] [Abstract][Full Text] [Related]
25. Pressor and tachycardic responses to intrathecal administration of neuropeptide FF in anesthetized rats.
Fang Q; Li N; Jiang TN; Liu Q; Li YL; Wang R
Peptides; 2010 Apr; 31(4):683-8. PubMed ID: 19922753
[TBL] [Abstract][Full Text] [Related]
26. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
[TBL] [Abstract][Full Text] [Related]
27. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
[TBL] [Abstract][Full Text] [Related]
28. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
29. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
[TBL] [Abstract][Full Text] [Related]
31. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
Kalra PS; Sahu A; Bonavera JJ; Kalra SP
Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
[TBL] [Abstract][Full Text] [Related]
33. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
Takano Y; Nakayama Y; Tateishi K; Saito R; Kamiya H
Neurosci Lett; 1992 May; 139(1):122-5. PubMed ID: 1328962
[TBL] [Abstract][Full Text] [Related]
34. Spinal action of neurokinins producing cardiovascular responses in the conscious freely moving rat: evidence for a NK-1 receptor mechanism.
Hasséssian H; Drapeau G; Couture R
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):649-54. PubMed ID: 2469023
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: systemic study in anesthetized rats.
Fu CY; Kong ZQ; Long Y; Chen Q; Wang R
Eur J Pharmacol; 2007 Oct; 572(2-3):175-81. PubMed ID: 17628523
[TBL] [Abstract][Full Text] [Related]
36. Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea.
Girard V; Félétou M; Advenier C; Canet E
Br J Pharmacol; 1997 Nov; 122(5):841-8. PubMed ID: 9384499
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats.
Kong ZQ; Fu CY; Chen Q; Wang R
Eur J Pharmacol; 2008 Aug; 590(1-3):310-6. PubMed ID: 18582457
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.
Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R
Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095
[TBL] [Abstract][Full Text] [Related]
39. Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors.
Mazzone SB; Geraghty DP
Br J Pharmacol; 1999 May; 127(2):473-81. PubMed ID: 10385248
[TBL] [Abstract][Full Text] [Related]
40. Effect of tachykinins on ascending and descending reflex pathway in rat small intestine.
Hahn A; Storr M; Allescher HD
Acta Pharmacol Sin; 2002 Apr; 23(4):289-95. PubMed ID: 11931700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
